• patient
  • In a trial HIV+ patient, the investigators have already demonstrated the efficacy of using botulinum toxin A in the treatment of posterior cheek enlargement, resulting from both parotid and masseter muscle enlargement. (clinicaltrials.gov)
  • In choosing the right cheek implant for any patient, three factors are considered…the selection of the patient, the size and shape of the implant, and properly positioning them during surgery. (exploreplasticsurgery.com)
  • Treatment
  • The investigators anticipate this study will increase our understanding of posterior cheek enlargement in HIV and lead to the development of a novel treatment for this important complication. (clinicaltrials.gov)
  • loss
  • An individual who has all of his or her teeth removed without replacement can and will likely have the appearance of loss of fullness of the cheek and lips. (healthtap.com)
  • result
  • The investigators hypothesize that posterior cheek enlargement in HIV+ patients will in some cases result from both masseter muscle hypertrophy as well as parotid gland enlargement. (clinicaltrials.gov)